FDA chief at odds with Congress

11/30/2006 | Washington Post, The

Dr. Andrew von Eschenbach, acting head of the FDA, refuses to give Congress all the information it seeks about the controversial antibiotic Ketek. Von Eschenbach said disclosure of the information could hinder the FDA's ability to independently and objectively evaluate drug safety and other issues. His position puts him on a collision course with Sen. Charles Grassley, R-Iowa, who is blocking Eschenbach's confirmation to be permanent head of FDA.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC